Kadimastem (XTAE:KDST) Valuation Rank

View and export this data going back to 2015. Start your Free Trial

What is Kadimastem Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Kadimastem Valuation Rank Related Terms

Thank you for viewing the detailed overview of Kadimastem's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Kadimastem (XTAE:KDST) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kadimastem Ltd (XTAE:KDST) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

KMSTF:USA

Address

Pinchas Sapir 7, Weizmann Science Park, Nes-Ziona, ISR

Website

http://www.kadimastem.com

Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. It is developing revolutionary regenerative therapies based on stem cells.